160 related articles for article (PubMed ID: 15872353)
1. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
[TBL] [Abstract][Full Text] [Related]
2. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
[TBL] [Abstract][Full Text] [Related]
3. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model.
Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2004 Dec; 45(12):2083-7. PubMed ID: 15585485
[TBL] [Abstract][Full Text] [Related]
4. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
Tokita N; Hasegawa S; Maruyama K; Izumi T; Blankenberg FG; Tait JF; Strauss HW; Nishimura T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model.
Kuge Y; Sato M; Zhao S; Takei T; Nakada K; Seki KI; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2004 Feb; 45(2):309-12. PubMed ID: 14960654
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
Song S; Xiong C; Lu W; Ku G; Huang G; Li C
J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
[TBL] [Abstract][Full Text] [Related]
9. Imaging of therapy-induced apoptosis using (99m)Tc-HYNIC-annexin V in thymoma tumor-bearing mice.
Wong E; Kumar V; Howman-Giles RB; Vanderheyden JL
Cancer Biother Radiopharm; 2008 Dec; 23(6):715-26. PubMed ID: 19111046
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
11. Effect of steroids on [18F]fluorodeoxyglucose uptake in an experimental tumour model.
Zhao S; Kuge Y; Nakada K; Mochizuki T; Takei T; Okada F; Tamaki N
Nucl Med Commun; 2004 Jul; 25(7):727-30. PubMed ID: 15208501
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of
Zheng J; Miao W; Huang C; Lin H
Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice.
Zhao Y; Kuge Y; Zhao S; Morita K; Inubushi M; Strauss HW; Blankenberg FG; Tamaki N
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1747-55. PubMed ID: 17437104
[TBL] [Abstract][Full Text] [Related]
14. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
Belhocine T; Steinmetz N; Hustinx R; Bartsch P; Jerusalem G; Seidel L; Rigo P; Green A
Clin Cancer Res; 2002 Sep; 8(9):2766-74. PubMed ID: 12231515
[TBL] [Abstract][Full Text] [Related]
15. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study of imaging paclitaxel-induced tumor apoptosis with (99)Tc(m)-His10-Annexin V.
Zheng YM; Wang F; Fang W; Hua ZC; Wang ZZ; Meng QL; Yan J
Chin Med J (Engl); 2013; 126(15):2928-33. PubMed ID: 23924470
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
[TBL] [Abstract][Full Text] [Related]
19. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models].
Lan XL; Zhang YX; He Y; Sun X; An R; Gao ZR; Cao GX
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
